Results 251 to 260 of about 3,288,372 (337)

Antiviral-resistant cytomegalovirus infections in solid organ transplantation in the Netherlands. [PDF]

J Antimicrob Chemother, 2019
Van Leer Buter CC, de Voogd DWK, Blokzijl H, de Joode AAE, Berger SP, Verschuuren EAM, Niesters HGM.   +6 more
europepmc   +1 more source

Manipulation of Wnt/β‐Catenin Signaling by Synthetic Frizzled Agonist and LRP Antagonist in Organoid Cultures and In Vivo

Small Methods, EarlyView.
Harnessing synthetic key receptor modulators, this study presents a breakthrough in Wnt/β‐catenin regulation. The FZD agonist RRP‐pbFn bypasses LRP5/6 to drive organoid expansion and tissue regeneration, while the LRP antagonist RRP‐Dkk1c eradicates tumors. These tools enable precise pathway control, advancing regenerative and cancer therapies.
Quanhui Dai, Jiawen Wang, Zihuan Lin, Danni Yu, Hui Yang, Jinsong Wei, Xiaoyu Li, Hao Hu, Chao Ni, Bing Zhao   +9 more
wiley   +1 more source

Is parvovirus B19 infection upsurge in 2023–2024 associated with adverse pregnancy outcome?

Ultrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objective A surge in parvovirus B19 infections has been reported in 2023–2024 across Europe and the USA, raising concerns about the associated perinatal risks. The aim of this study was to compare perinatal outcomes following maternal parvovirus B19 infection during the 2023–2024 period with those from a pre‐2023 cohort.
S. Prasad, A. Khalil, Y. Yinon, N. Regev, R. Brawura‐Biskupski‐Samaha, M. Massoud, N. Mazanowska, F. G. Sileo, F. Prefumo, P. Kosinski, J. Morales Rosello, F. D'Antonio, Collaborators, C. Ozan Ulusoy, D. Mohammed, M. Arora, A. Hegde, E. Klapholz, C. Berkovitz, K. Kosińska‐Kaczyńska, I. Rzucidło‐Szymańska, N. Szymecka‐Samaha, S. Ceffa   +22 more
wiley   +1 more source

ZBTB32 restrains antibody responses to murine cytomegalovirus infections, but not other repetitive challenges. [PDF]

Sci Rep, 2019
Jash A, Zhou YW, Gerardo DK, Ripperger TJ, Parikh BA, Piersma S, Jamwal DR, Kiela PR, Boon ACM, Yokoyama WM, Hsieh CS, Bhattacharya D.   +11 more
europepmc   +1 more source

Targeting KDM1A suppresses G6PD expression to induce oxidative stress and ferroptosis in TP53‐mutated liver cancer

VIEW, EarlyView.
TP53‐mutant HCC is aggressive and often resistant to treatment. In this study, we found that KDM1A is highly expressed in TP53‐mutant HCC and promotes tumor growth while preventing ferroptosis by activating the pentose phosphate pathway (PPP). Targeting KDM1A, especially in combination with sorafenib, may offer a promising therapeutic strategy for this
Songling Li, Wenyun Guo, Yifei Qian, Linfeng Li, Qianyu Li, Zijun Zhu, Wenli Qin, Wang Li, Yunfeng Yuan, Wei‐Qiang Gao, Yanfeng Liu   +10 more
wiley   +1 more source

Cyclophilin A as a target in the treatment of cytomegalovirus infections. [PDF]

Antivir Chem Chemother, 2018
A Abdullah A, Abdullah R, A Nazariah Z, N Balakrishnan K, Firdaus J Abdullah F, A Bala J, Mohd-Lila MA.   +6 more
europepmc   +1 more source

A submucosal antral mass caused by cytomegalovirus infection in a patient with acquired immunodeficiency syndrome. [PDF]

, 1986
Grace H. Elta, Richard H. Turnage, Frederic E. Eckhäuser, Farooq P. Agha, Stephen C. Ross   +4 more
openalex  

Comparison of the Pathogenesis of Murine Cytomegalovirus in Lung and Liver Following Intraperitoneal or Intratracheal Infection

, 1984
MaryJane K. Selgrade, Albert M. Collier, L. Saxton, Michael J. Daniels, Josh Graham   +4 more
openalex   +1 more source